Biopharmaceutical formulation and stability systems: Meiji Holdings Last 5 Years research landscape
Protein aggregation and photodegradation of active ingredients during storage limit the shelf life and safety of injectable blood factors and oral medications.
What technical problems is Meiji Holdings addressing in Biopharmaceutical formulation and stability systems?
Insoluble matter formation
(7) documents
Storage-induced protein aggregation and photolytic degradation of active ingredients cause visible particulate formation in pharmaceutical containers.
